These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21690623)

  • 61. Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.
    Taylor ME; Allon M
    Am J Kidney Dis; 2010 Jun; 55(6):1163-5. PubMed ID: 20497837
    [No Abstract]   [Full Text] [Related]  

  • 62. Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmanova H; Urbanek K; Grundmann M; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):342-7. PubMed ID: 22660225
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.
    Buckel WR; Ghobrial S; Tamma PD; Milstone AM; Zhao Y; Hsu AJ
    Paediatr Drugs; 2017 Feb; 19(1):43-51. PubMed ID: 27873214
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.
    Pawlotsky F; Thomas A; Kergueris MF; Debillon T; Roze JC
    Br J Clin Pharmacol; 1998 Aug; 46(2):163-7. PubMed ID: 9723826
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prescribing habits of vancomycin in the Emergency Department: are we dosing appropriately?
    Rosini JM; Grovola MR; Levine BJ; Jasani NB
    J Emerg Med; 2013 May; 44(5):979-84. PubMed ID: 23466019
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictive performance of pharmacokinetic models for outpatients receiving vancomycin continuous infusion.
    Ng TM; Lye DC; Chan M; Tam VH
    Int J Antimicrob Agents; 2014 Feb; 43(2):197-9. PubMed ID: 24359843
    [No Abstract]   [Full Text] [Related]  

  • 67. Validation of two vancomycin nomograms in patients 10 years of age and older.
    Gillon JE; Cassat JE; Di Pentima MC
    J Clin Pharmacol; 2014 Jan; 54(1):35-8. PubMed ID: 24249098
    [No Abstract]   [Full Text] [Related]  

  • 68. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
    Rybak M; Lomaestro B; Rotschafer JC; Moellering R; Craig W; Billeter M; Dalovisio JR; Levine DP
    Am J Health Syst Pharm; 2009 Jan; 66(1):82-98. PubMed ID: 19106348
    [No Abstract]   [Full Text] [Related]  

  • 69. Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
    Maxson R; Pate J; Starr J
    Ren Fail; 2016 Nov; 38(10):1677-1682. PubMed ID: 27756193
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.
    Lee P; DiPersio D; Jerome RN; Wheeler AP
    J Med Libr Assoc; 2007 Oct; 95(4):374-80. PubMed ID: 17971884
    [No Abstract]   [Full Text] [Related]  

  • 71. Nursing behaviors related to vancomycin and aminoglycoside administration.
    Anderson BC; Crader MF; Nix ES; McDaniel M
    Medsurg Nurs; 2012; 21(6):378-82, 384. PubMed ID: 23477032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Creatinine Clearance Estimations for Vancomycin Maintenance Dose Adjustments.
    Šíma M; Hartinger J; Štenglová Netíková I; Slanař O
    Am J Ther; 2018; 25(5):e602-e604. PubMed ID: 28650911
    [No Abstract]   [Full Text] [Related]  

  • 73. Once-weekly vancomycin for patients receiving high-flux hemodialysis.
    Crawford BS; Largen RF; Walton T; Doran JJ
    Am J Health Syst Pharm; 2008 Jul; 65(13):1248-53. PubMed ID: 18574015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential utility for nomogram-based vancomycin dosing.
    Elshaug EK; Manning L; Rawlins MD; Ridley BL; Ingram PR
    Int J Infect Dis; 2013 May; 17(5):e355-6. PubMed ID: 23218547
    [No Abstract]   [Full Text] [Related]  

  • 75. Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin.
    Cahane M; Ben Simon GJ; Barequet IS; Grinbaum A; Diamanstein-Weiss L; Goller O; Rubinstein E; Avni I
    Br J Ophthalmol; 2004 Jan; 88(1):22-4. PubMed ID: 14693765
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Computerized provider order entry improves compliance of vancomycin dosing guidelines in the emergency department.
    Frankel KC; Rosini JM; Levine BJ; Papas MA; Jasani NB
    Am J Emerg Med; 2013 Dec; 31(12):1715-6. PubMed ID: 24144562
    [No Abstract]   [Full Text] [Related]  

  • 77. Impact of a 20 mg/kg vancomycin loading dose on early AUC target attainment.
    Yang S; Antoniello A; Smoke S
    Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116355. PubMed ID: 38788550
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation of vancomycin clearance and creatinine clearance: unreliability for predicting initial dosing in neutropenic haematological patients.
    Soto J; Alsar MJ; Chantal P; Sacristán JA
    J Antimicrob Chemother; 1993 Dec; 32(6):920-2. PubMed ID: 8144443
    [No Abstract]   [Full Text] [Related]  

  • 79. New hemodialysis membranes and vancomycin clearance.
    Meyer CC; Calis KA
    Am J Health Syst Pharm; 1995 Dec; 52(24):2794-6. PubMed ID: 8748565
    [No Abstract]   [Full Text] [Related]  

  • 80. Can a vancomycin assay be utilised to predict plasma telavancin concentrations?
    Evans DJ; Windisch RM; Freedy HR; Bonilla HF
    Int J Antimicrob Agents; 2013 May; 41(5):495-7. PubMed ID: 23523732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.